Medically reviewed by Doru Paul, MD Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow.

Vusolimogene oderparepvec is under clinical development by Replimune and currently in Phase II for Non-Small Cell Lung Cancer.

Navi Mumbai: In a medical breakthrough at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, a 39-year-old Rijesh Nair, a ...

Sargramostim is under clinical development by Partner Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer.

A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...

One Burleson family has received the best Christmas presents imaginable this year. On Dec. 11, they received the news that ...

In April 2022, the world was returning to normal after months of lockdowns – but life for Chloe Askew was about to be turned ...

UCSF scientists have discovered a stem cell in the young brain that's capable of forming the cells found in tumors. The ...

Deep sleep may clear the brain of toxic waste via a process driven by norepinephrine, a molecule that creates rhythmic blood vessel contractions.

“We are exploring how CSF and blood biomarkers change over the continuum ... miR-145 as a potential biomarker and therapeutic target in patients with non-small cell lung cancer. Int J Mol Sci. 2023;24 ...